Volume 85 Issue 3 | pp. 38-39
Issue Date: January 15, 2007

Back To Basics

Under new owner Danisco, Genencor drops health care strategy and focuses on enzymes
Department: Business

During the first four years of the decade, Genencor was an industrial enzymes producer with high aspirations: It wanted to parlay its biotechnology skills into success in the lucrative pharmaceutical industry.

But everything changed in early 2005, when Danisco, a Danish food and feed ingredients company and one of Genencor's two large shareholders, struck a deal to buy out Eastman Chemical, the other big shareholder. Danisco then snapped up Genencor's publicly traded shares . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society